Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Pliant Therapeutics Inc stock

Learn how to easily invest in Pliant Therapeutics Inc stock.

Pliant Therapeutics Inc is a biotechnology business based in the US. Pliant Therapeutics Inc shares (PLRX) are listed on the NASDAQ and all prices are listed in US Dollars. Pliant Therapeutics Inc employs 110 staff and has a trailing 12-month revenue of around $9.8 million.

How to buy shares in Pliant Therapeutics Inc

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PLRX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Pliant Therapeutics Inc stock price (NASDAQ: PLRX)

Use our graph to track the performance of PLRX stocks over time.

Pliant Therapeutics Inc shares at a glance

Information last updated 2022-09-25.
Latest market close$19.83
52-week range$3.97 - $24.81
50-day moving average $19.95
200-day moving average $12.01
Wall St. target price$43.11
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.85

Buy Pliant Therapeutics Inc shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$100
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Pliant Therapeutics Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Pliant Therapeutics Inc price performance over time

Historical closes compared with the close of $19.83 from 2022-09-23

1 week (2022-09-15) N/A
1 month (2022-08-22) 4.53%
3 months (2022-06-24) 142.42%
6 months (2022-03-25) 163.35%
1 year (2021-09-24) 12.16%
2 years (2020-09-25) -7.94%
3 years (2019-09-22) N/A
5 years (2017-09-22) N/A

Pliant Therapeutics Inc financials

Revenue TTM $9.8 million
Gross profit TTM $7.6 million
Return on assets TTM -31.1%
Return on equity TTM -55.76%
Profit margin 0%
Book value $4.09
Market capitalisation $965.4 million

TTM: trailing 12 months

Pliant Therapeutics Inc share dividends

We're not expecting Pliant Therapeutics Inc to pay a dividend over the next 12 months.

Pliant Therapeutics Inc share price volatility

Over the last 12 months, Pliant Therapeutics Inc's shares have ranged in value from as little as $3.965 up to $24.81. A popular way to gauge a stock's volatility is its "beta".

PLRX.US volatility(beta: 1.47)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Pliant Therapeutics Inc's is 1.472. This would suggest that Pliant Therapeutics Inc's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Pliant Therapeutics Inc overview

Pliant Therapeutics, Inc. , a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which completed Phase 1 clinical trial for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition, it is developing two additional preclinical integrin-based programs, which include an oncology program, as well as a program for an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor for treatment of muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Frequently asked questions

What percentage of Pliant Therapeutics Inc is owned by insiders or institutions?
Currently 6.655% of Pliant Therapeutics Inc shares are held by insiders and 61.149% by institutions.
How many people work for Pliant Therapeutics Inc?
Latest data suggests 110 work at Pliant Therapeutics Inc.
When does the fiscal year end for Pliant Therapeutics Inc?
Pliant Therapeutics Inc's fiscal year ends in December.
Where is Pliant Therapeutics Inc based?
Pliant Therapeutics Inc's address is: 260 Littlefield Avenue, South San Francisco, CA, United States, 94080
What is Pliant Therapeutics Inc's ISIN number?
Pliant Therapeutics Inc's international securities identification number is: US7291391057
What is Pliant Therapeutics Inc's CUSIP number?
Pliant Therapeutics Inc's Committee on Uniform Securities Identification Procedures number is: 69912C105

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site